When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
Arvinder Dhalla, PhD, Rani Therapeutics; Victoria S. Ochs, BS, Indiana University School of Medicine; and Amanda Godoi, Cardiff University, discussed research findings at an ENDO 2023 press conference.…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses the treatment of large kidney tumors. Historically, most kidney cancers presented as large masses, but with advancements in…
Dr. Caitlin McMullen and panelists Dr. Kedar Kirtane, Dr. Sarimar Agosto Salgado, and Barb Wampler, RN, discuss new therapies and clinical trial development in head and neck and…
In this episode, Becket talks with Monique Ruberu, MD, an OB/GYN in Philadelphia, about the ethics of IVF, contraceptives, and NaPro technology. Contraceptives are not only dangerous for…
Peter Attia, MD, joins MedCram to discuss the optimization of cancer screening using various techniques, including information on timing, imaging (full body MRI, etc), and liquid biopsies. Dr…
Larry W. Moreland, MD, professor of medicine and orthopedics, Division of Rheumatology, University of Colorado School of Medicine, discusses treatment strategies for rheumatoid arthritis. Dr Moreland discusses the…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
Rajiv Agarwal, MD, BS, a renowned nephrology expert, discusses the importance of early detection and treatment of chronic kidney disease (CKD), particularly in patients with type 2 diabetes.…
Surya Seshan, MBBS, of New York-Presbyterian Hospital and Weill Cornell Medical College, discusses the basics of antiphospholipid antibody syndrome, first described by Professor Hughes in the 1980s. The…
